These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31654330)

  • 21. Ceftriaxone-associated biliary pseudolithiasis in children.
    Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
    J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftriaxone-associated gallbladder pseudolithiasis: report of one case.
    Wen HH; Huang YK; Zheng GL
    Acta Paediatr Taiwan; 2004; 45(5):290-2. PubMed ID: 15868813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pseudolithiasis caused by ceftriaxone in children: a case report].
    Benedetti M; Zanchetta S; Bagnani A; Praderio R; Perbellini S; Melo C
    Pediatr Med Chir; 1995; 17(4):369-71. PubMed ID: 7491336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children.
    Ozturk A; Kaya M; Zeyrek D; Ozturk E; Kat N; Ziylan SZ
    Acta Radiol; 2005 Feb; 46(1):112-6. PubMed ID: 15841750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftriaxone and pseudolithiasis in older people.
    Miyamoto T; Ebihara T; Kozaki K
    Geriatr Gerontol Int; 2018 Mar; 18(3):507-509. PubMed ID: 29542293
    [No Abstract]   [Full Text] [Related]  

  • 26. Pseudolithiasis after recent use of ceftriaxone: an unexpected diagnosis in a child with abdominal pain.
    von Martels JZ; Van de Meeberg EK; Holman M; Ligtenberg JJ; Ter Maaten JC
    Am J Emerg Med; 2013 Aug; 31(8):1294.e5-6. PubMed ID: 23809091
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
    Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
    Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
    Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sonographic demonstration of pseudo-cholelithiasis after ceftriaxone].
    Barzilai M
    Harefuah; 1994 Sep; 127(5-6):163-5, 215. PubMed ID: 7995584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of ceftriaxone-associated gallbladder pseudolithiasis.
    Papadopoulou F; Efremidis S; Karyda S; Badouraki M; Karatza E; Panteliadis C; Malaka K
    Acta Paediatr; 1999 Dec; 88(12):1352-5. PubMed ID: 10626521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftriaxone-induced symptomatic pseudolithiasis mimicking ICP elevation.
    Evliyaoglu C; Kizartici T; Bademci G; Unal B; Keskil S
    Zentralbl Neurochir; 2005 May; 66(2):92-4. PubMed ID: 15846537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudolithiasis due to ceftriaxone treatment for meningitis in children: report of 8 cases.
    Araz N; Okan V; Demirci M; Araz M
    Tohoku J Exp Med; 2007 Mar; 211(3):285-90. PubMed ID: 17347554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftriaxone-associated Biliary Pseudolithiasis with Elderly Type 1 Diabetes Mellitus: Two Case Reports.
    Kanazawa K; Suzuki S; Inaba T; Koga S; Kuwabara K
    Intern Med; 2023 Nov; 62(22):3367-3371. PubMed ID: 37032086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliary pseudolithiasis in childhood: a case report.
    Herek O; Sarioğlu A; Koçer N; Tiryaki A; Akkemik B
    Eur J Pediatr Surg; 1999 Oct; 9(5):337-9. PubMed ID: 10584197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in Chinese children.
    Meng D; Cao Y; Fu J; Chen R; Lu L; Tu Y
    J Int Med Res; 2010; 38(6):2004-10. PubMed ID: 21227004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Symptomatic pseudolithiasis caused by Rocephalin].
    Tuckuviene R; Myrtue GS
    Ugeskr Laeger; 2000 Aug; 162(32):4271-2. PubMed ID: 10962947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ceftriaxone-associated biliary pseudolithiasis in a child].
    Wang YQ
    Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):251. PubMed ID: 15924712
    [No Abstract]   [Full Text] [Related]  

  • 38. [Case report; a case of biliary pseudolithiasis associated with ceftriaxone].
    Hanata N; Imamura T; Koyama R; Koizumi Y; Tamura T; Ito J; Takeuch K
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2955-7. PubMed ID: 23214106
    [No Abstract]   [Full Text] [Related]  

  • 39. Apparent biliary pseudolithiasis during ceftriaxone therapy.
    Heim-Duthoy KL; Caperton EM; Pollock R; Matzke GR; Enthoven D; Peterson PK
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1146-9. PubMed ID: 2203305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ceftriaxone-associated biliary pseudolithiasis in a child with nephrotic syndrome].
    Zheng FY; Xing Y; Lu S; Liu DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):696-7. PubMed ID: 23965889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.